ArticleBlood2015

AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia.

Donya Moradi Manesh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.